Arvind Remedies gains on establishing new manufacturing facility near Chennai

26 Jun 2013 Evaluate

Arvind Remedies is currently trading at Rs 27.60, up by 0.55 points or 2.03% from its previous closing of Rs 27.05 on the BSE.

The scrip opened at Rs 27.15 and has touched a high and low of Rs 27.90 and Rs 27.15 respectively. So far 8989 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 40.05 on 13-Sep-2012 and a 52 week low of Rs 21.00 on 28-Jun-2012.

Last one week high and low of the scrip stood at Rs 29.35 and Rs 26.70 respectively. The current market cap of the company is Rs 133.11 crore.

The promoters holding in the company stood at 46.84%, while Non-Institutions held 53.16% stake.

Arvind Remedies has established an Rs 250-crore manufacturing facility at Irungattukottai, near Chennai, in order to tap the US market. It has begun with testing and development of analgesic and cardiac generic drugs (tablets) at the plant, which will seek USFDA approval in next six months.

The company has also established a subsidiary in New Jersey to take care of its US strategy. It is likely to distribute its drugs in the US and also get into contract manufacturing for other American pharma companies.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×